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Using Collaboration and a Data Registry to Answer Our
Burning Questions Regarding Fetal Cardiac Intervention*Mary T. Donofrio, MDT echnological advances in fetal cardiac imag-ing have given us a window into the womb,creating the ﬁeld of fetal cardiology, where
the fetus is considered an individual patient from
the time of diagnosis. One of the challenges we face
as fetal caregivers is that we must strive to understand
the “prequel” of what we already know; the natural
history and progression of congenital heart disease
in utero. More than 25 years ago, researchers reported
that structural heart disease, speciﬁcally aortic steno-
sis, evolves in utero (1). Fetal therapy, either by
catheter intervention or surgery, is based on the
fundamental principle that intervention will alter
the natural history of the disease process. To prove
that this is true, we must ﬁrst gain an understanding
of the unaltered progression of heart disease in utero.
In addition, we must have measurable goals that we
hope to achieve, whether it be to completely reverse
the process of progression of valve disease to hypo-
plastic right or left heart syndrome or to minimize
myocardial and/or end-organ injury in fetuses with
impaired perfusion or myocardial performance. Fore-
most in the design of fetal intervention techniques is
the principle that there are 2 patients to consider
and the risk to the mother must be minimized. For
this reason, catheter-based intervention is appealing.
The concept of fetal intervention is not new, with
techniques and outcomes reported for fetal diagnoses
that include twin-twin transfusion, hydrocephalus,
myelomeningocele, obstructive uropathy, and dia-
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credited with the ﬁrst report of intervention in 2
fetuses for evolving hypoplastic left heart syndrome
(HLHS) performed in 1991. The technique was aban-
doned after a series of cases was reported (4), partly
due to improved surgical outcomes for HLHS. Subse-
quently, review of the world experience of fetal aortic
valvuloplasty showed disappointing outcomes, with
only 1 of 12 fetuses going on to have a 2 ventricular
repair (5), further discouraging advancement of the
ﬁeld. A similar fate was had for fetuses with severe
pulmonary valve disease with the ﬁrst report in
2002 (6) and limited acceptance thereafter. In 2004,
Tworetzky et al. (7) published the experience at Bos-
ton Children’s Hospital, rejuvenating both interest
and controversy. Aortic valvuloplasty was success-
fully performed in 14 of 20 fetuses, of whom 3 went on
to have a biventricular circulation. In 2009, the group
reported additional outcomes in 70 fetuses (8), 52 of
whom had a technically successful intervention with
17 achieving a biventricular circulation. Since their
original report, the group has gone on to perform
>100 procedures and has reported on technique,
outcomes, and criteria for successful intervention
(8,9). Other investigators have achieved similar re-
sults. In Austria, 16 of 23 fetuses had a successful
intervention for aortic stenosis, with 10 achieving a
biventricular circulation (10).
Despite single-center reports of success, uncer-
tainty persists, and acceptance of fetal cardiac inter-
vention remains limited, partly due to unanswered
questions regarding the natural progression of aortic
stenosis to HLHS in utero and the lack of formalized
study of the procedure and outcomes. Recently, the
American Heart Association released the ﬁrst scien-
tiﬁc statement on the diagnosis and treatment of fetal
cardiac disease (11). Comprehensive reviews of pub-
lished reports revealed that there was not signiﬁcant
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for fetal cardiac intervention, given that studies had
small sample sizes, no control groups, and no long-
term follow-up. The statement concluded, “Given
the rarity of many conditions, national and interna-
tional multidisciplinary collaboration is essential as
we embrace our role as specialized caregivers for
fetuses with cardiovascular disease” (11).
This is not a new concept. In 2005, Kleinman (12)
compared the experience and challenges of fetal car-
diac intervention to that of treating myelomeningo-
celes, in a U.S. National Institutes of Health trial in
which enrollment was affected by anecdotal clinical
experience, setting up a bias that the procedure was
effective. The author stated “Recent articles in the lay
press have popularized the notion that fetal cardiac
intervention is an innovative but accepted therapy,
and multiple centers have attempted a handful of
such procedures with variable degrees of success”
(12). He suggested a prospective multicenter trial to
address the nuances of technical performance of the
procedure, to evaluate short-term and mid-term re-
sults, and to compare these results with those of
children undergoing various forms of palliation for
HLHS. An alternative plan proposed by Mellander
et al. (13) to create a registry, though not ideal, offered
a reasonable alternative. The authors state, “Although
randomized trials would be desirable, the practical
issues of recruiting sufﬁcient sample sizes and con-
trolling for variation in practice across multiple sites is
not to be underestimated. Multicenter registries,
analyzed free of bias, may be an alternative way to
improve the evidence base of fetal cardiac therapy.”SEE PAGE 388In this issue of the Journal, Moon-Grady et al. (14)
have taken on the task of pulling together experts in
the ﬁeld to collaborate and create the International
Fetal Cardiac Intervention Registry (IFCIR) to build
the platform needed to gather the data we have been
calling for over the past decade. This article repre-
sents the initial report of the registry and sets the
groundwork for future publications from this rich and
expanding dataset. Established in 2010, the IFCIR
collects data for maternal/fetal dyads and newborns
who were referred and evaluated as possible candi-
dates for fetal cardiac intervention. Forty institutions
from 15 countries are represented, and 370 cases have
been entered thus far, 245 of whom had an inter-
vention, including 186 aortic valvuloplasties (of
which 100 from 1 institution were excluded in order
to remove overlap and facilitate comparison), 16
pulmonary valvuloplasties, 37 atrial septal cases of
HLHS, and 6 unclassiﬁed cases. The majority ofinterventions were performed percutaneously with
either regional or local anesthesia. Of 15 centers
reporting an intervention, case volume ranged from 1
to 132, with 7 performing 3 or fewer cases and 2
reporting more than 20 cases.
Exploratory analysis of the data was performed to
compare outcomes of the intervention group versus
those of patients who met criteria but who had no
intervention or had an unsuccessful one. Overall
survival was not affected by intervention; fetal sur-
vival to live birth was 80.0% in the intervention group
and 85.2% in the nonintervention group; survival to
discharge was 57.5% and 59.3%, respectively. In the
subgroup of fetuses with aortic stenoses and evolving
HLHS, live-born infants were more than twice as
likely to be discharged with a biventricular circulation
after successful fetal intervention than those who had
no fetal intervention or the intervention was unsuc-
cessful (42.9% vs. 19.4%, respectively). When fetal
deaths were counted as intervention failures, out-
comes were similar, with an increased percentage of
patients discharged with a biventricular circulation
after successful intervention (31.3% vs. 18.5%,
respectively). Of HLHS fetuses considered for atrial
septal intervention, 37 underwent interventions.
There were no differences in overall survival,
although diagnostic criteria for intervention were not
uniform. Finally, 16 fetuses underwent pulmonary
valvuloplasty; of these, 42.9% were discharged with
biventricular circulation compared to 37.5% who were
discharged without intervention.
Comparison of IFCIR outcomes after fetal aortic
valvuloplasty to those of recently published data
from single-center reveals similar ﬁndings. In Boston
(9), 77% of fetuses had a successful intervention,
with 45% resulting in a biventricular outcome. In
Austria (10), after an early “learning curve,” 79%
of interventions were successful, with 67% of in-
terventions achieving biventricular circulation.
Similarly, registry data revealed that 81% of fetuses
with aortic stenoses had a technically successful
intervention and that 43% of those who were live-
born were discharged with biventricular circulation.
Additionally, despite concerns regarding differences
in post-natal care and catheter and surgical strate-
gies, the percentage of registry patients who ulti-
mately had biventricular repair matched the
outcomes in the larger, single-center Boston and
Austrian experiences (9,10). Finally, the overall reg-
istry procedure-related complication rates were
similar to those of the Boston and Austria experiences.
These data all support the concept that the procedure
can be done successfully in specialized centers as long
as expertise is present.
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data to draw overarching conclusions and make
deﬁnitive recommendations. First and foremost, the
lack of randomization precludes a true control group
to determine whether those who receive interven-
tion have outcomes similar to those who do not.
Although this issue is addressed by using fetuses
with unsuccessful interventions as control subjects,
this is not ideal and not truly representative of the
affected population. Second, there is no uniformly
accepted strategy for determining post-natal surgical
care for these patients, including accepted criteria
for biventricular repair. It is important to note that
post-natal management is essential to treating new-
borns with aortic stenoses and a borderline left
ventricle. Key factors, including access to specialized
interventional catheterization procedures and inno-
vative surgical techniques, must be considered.
Different care strategies from individual practices
may introduce center bias, making it difﬁcult to
ascertain whether fetal intervention or specialized
post-natal care determines success. Also, although
most practitioners believe it is more beneﬁcial for a
patient to have biventricular repair than single-
ventricle palliation, the long-term beneﬁts of strate-
gies that begin with fetal intervention remain
unknown. Comparative analysis of long-term out-
comes of fetal intervention as an alternate strategy
through detailed follow-up is imperative. Finally,
alterations in brain development and brain injury in
fetuses with aortic stenosis versus those with HLHS
will need to be addressed. Data suggest that lack ofantegrade aortic ﬂow may have an impact on brain
maturation in the third trimester (15). Careful
assessment of brain development and injury in
fetuses with aortic stenosis post-fetal intervention
will need to be investigated.
In conclusion, the power is truly in the numbers.
Individual centers have shown that fetal cardiac
intervention can be performed successfully, with
minimal risk to the mother and encouraging out-
comes for fetuses, particularly in those with aortic
stenoses evolving to HLHS. This ﬁrst IFCIR report (14)
has shown that fetal cardiac intervention is being
performed successfully worldwide, that the proce-
dure has now become safer using percutaneous ac-
cess and local or regional anesthesia, and that
pregnancy outcomes and survival rates are similar,
despite different practices in post-natal care. Given
the small number of fetuses with cardiac defects
amenable to fetal intervention, a multicenter ran-
domized trial is unlikely. It is imperative, however,
that we continue to move forward in the ﬁeld. Only if
we work together and collaborate as a medical com-
munity, pooling our experiences and data, will we
succeed. The IFCIR represents a major step forward in
the ﬁeld of fetal cardiology. Hopefully, the answers to
our burning questions are close at hand.
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